International Journal of Radiation Oncology*Biology*Physics
Clinical InvestigationPatterns of Retropharyngeal Node Metastasis in Nasopharyngeal Carcinoma
Introduction
Nasopharyngeal carcinoma (NPC) is common among Asians, especially in southern China. The nasopharynx has a well-developed network of lymphatics, and cervical lymphadenopathy is common in NPC. Most patients with NPC (60–90%) have nodal metastases at presentation on computed tomography (CT) or magnetic resonance (MR) imaging 1, 2, 3, 4, 5, 6, 7. Because radiotherapy is the standard treatment of both the primary tumor and nodal metastases in NPC, the pattern of nodal spread has an important bearing on radiotherapy treatment planning. The retropharyngeal lymph nodes (RLN) and cervical Level II nodes have been reported to be the most commonly involved nodal regions 3, 4, 5, 7. Despite the high incidence of metastasis to the RLN in NPC, its prognostic significance has not been fully resolved 8, 9, 10, and the recommendations in published staging systems that pertain to RLN involvement are ambiguous 11, 12. Data describing RLN spread patterns based on radiographic observations will provide critical guidance for further research on prognostic significance and staging categories.
The relationships between RLN metastasis and primary tumor extensions and cervical nodal metastases are useful for clarifying the patterns of lymphatic drainage and nodal metastases in NPC but have not yet been thoroughly investigated. Liu et al.(7) and Chua et al.(8) observed a higher incidence of enlarged RLN associated with oropharyngeal, parapharyngeal, and cervical lymph node involvement. Lam et al.(13) found a statistical association between RLN metastasis and Level II node involvement but not with other groups of neck nodes. Apart from these three articles, there is little published information concerning the relationship between RLN metastasis and tumor extensions in NPC. Furthermore, there is no consensus as to whether RLN are the first-echelon nodes. Retropharyngeal lymph nodes had been regarded as the first-echelon nodes of NPC 3, 14, but the findings of Shu-Hang Ng et al.(15) indicate that RLN are involved less frequently than cervical nodes. The aims of our study were to analyze the incidence, number, and distribution of RLN metastases in a cohort of patients with NPC and to examine through MR imaging the relationship of these metastases with primary tumor extension and cervical lymphadenopathy to document patterns of RLN spread.
Section snippets
Patients
From January 2005 to December 2006, 618 patients with pathologically confirmed NPC were treated at our hospital. All patients underwent pretreatment evaluation that consisted of a complete history, physical examination, hematology and biochemistry profiles, MR scan of the nasopharynx and neck, chest radiography, and abdominal sonography; patients with T3 or T4 disease, low cervical metastasis, or a lymph node >4 cm also underwent whole-body bone scan. Disease was staged according to the 2002
Incidence and distribution of nodal metastasis
Of 618 patients, 543 (87.8%) had nodal involvement. Of these 543 patients, 35 (6.5%) had RLN metastasis only, 151 (27.8%) had cervical lymph node metastasis only, and 357 (65.7%) exhibited involvement of both the RLN and cervical lymph nodes. The incidence of RLN metastasis was lower than that of cervical lymphadenopathy (72.2% vs. 93.5%). The distribution of metastatic node sites in these 543 patients is shown in Table 2.
Incidence and distribution of RLN metastasis
A total of 597 involved RLN were detected in 392 patients (63.4%). The
Discussion
Because of the anatomic location of NPC, radiotherapy is the mainstay treatment modality for NPC. Therefore, this study bears a limitation inherent to studies of this disease, namely the lack of opportunity for histologic confirmation of imaging findings. Retropharyngeal lymph nodes are located deep within the neck and in NPC are close to the primary tumor; they are poorly accessible by image-guided fine-needle aspiration biopsy. So it is particularly difficult to define radiologic criteria of
Acknowledgment
The authors thank Professor Taifu Liu for revising the manuscript.
References (34)
- et al.
Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma
Eur J Radiol
(1995) - et al.
Computed tomography evaluation of neck node metastases from nasopharyngeal carcinoma
Int J Radiat Oncol Biol Phys
(1993) - et al.
Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: Patterns of spread
Int J Radiat Oncol Biol Phys
(2006) - et al.
Prognostic factors of nasopharynx tumor investigated by MR imaging and the value of MR imaging in the newly published TNM staging
Int J Radiat Oncol Biol Phys
(1999) - et al.
Prognostic influence of parapharyngeal space involvement in nasopharyngeal carcinoma
Int J Radiat Oncol Biol Phys
(2002) - et al.
CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines
Radiother Oncol
(2003) - et al.
MR study of lateral retropharyngeal lymph nodes at different ages
Oral Surg Oral Med Oral Pathol Oral Radiol Endo
(2004) Can Rouviere's lymph nodes in non-malignant subjects be identified with MRI?
Auris Nasus Larynx
(1993)- et al.
Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma
Eur J Radiol
(1995) - et al.
Retropharyngeal nodes in squamous cell carcinoma of oropharynx: Incidence, localization, and implications for target volume
Int J Radiat Oncol Biol Phys
(2006)
Staging of nasopharyngeal carcinoma: Suggestions for improving the current UICC/AJCC staging system
Clin Oncol
Nasopharyngeal carcinoma: MRI and CT assessment
Neuroradiology
Neck node metastases from nasopharyngeal carcinoma: MRI of patterns of disease
Head Neck
Analysis of computed tomography-based distribution of metastatic cervical nodes in 218 cases of nasopharyngeal carcinoma
Ai Zheng
Comparison of 18F-2-fluoro-2- deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma
Ann Otol Rhinol Laryngol
Retropharyngeal lymphadenopathy in patients with nasopharyngeal carcinoma
Cancer
American Joint Committee on Cancer: AJCC cancer staging manual
Cited by (60)
Statin use reduces radiation-induced stroke risk in advanced nasopharyngeal carcinoma patients
2024, Radiotherapy and OncologyRadiotherapy for nasopharyngeal cancer
2022, Cancer/RadiotherapieMR Imaging of Nasopharyngeal Carcinoma
2022, Magnetic Resonance Imaging Clinics of North AmericaCitation Excerpt :Nodes are frequently bilateral and may show necrosis and extranodal spread. The first groups of metastatic spread are either the lateral retropharyngeal or the upper internal jugular chain (level II), especially those that lie posterior to the vein (IIA and IIB).6,7,34,35 The lateral retropharyngeal nodes are located between the internal carotid artery and the anterolateral margin of the prevertebral muscle and extend from approximately the level of the lateral recess of the nasopharynx to the third cervical vertebra.6
Essential imaging of the nasopharyngeal space with special focus on nasopharyngeal carcinoma
2021, Operative Techniques in Otolaryngology - Head and Neck SurgeryCitation Excerpt :Due to their deep location, detection by physical examination is difficult but these nodes can be demonstrated with MRI (Figure 4a). Nodal metastases typically spread sequentially down the neck to the supraclavicular fossa (Figure 4b), although skip metastases can sometimes occur.25,27,28 Submandibular and parotid nodal metastases are infrequent and are usually associated with disease in the ipsilateral retropharyngeal nodes or level II nodes.25,29
Management of retropharyngeal lymph node metastasis in oral cancer
2019, Oral OncologyCitation Excerpt :In this study, RPLN metastases had poorer prognosis (38.1%) than general CLN metastases (71.3%), but our results suggest that early detection of resectable stage and surgical excision (80%) may help improve the prognosis of RPLN metastasis in oral cancer. The frequency of RPLN metastases in pharyngeal cancer was reported to be 64–75% in the nasopharynx [7–9], 10–16% in the oropharynx [10–12], and 16–20% in the hypopharynx [13–15]. In contrast, the frequency of RPLN metastases in oral cancer was reported to be <1% [4,16].
Current thinking on the management of abnormal retropharyngeal nodes in patients with oral, oropharyngeal, and nasopharyngeal squamous cell carcinoma: a structured review
2019, British Journal of Oral and Maxillofacial Surgery
Conflict of interest: none.